Tag:
GDC-0973
Latest Headlines
Latest Headlines
Genentech drug looks promising in early breast-cancer trial
Tests of an experimental Genentech treatment are showing some early promise in advanced breast-cancer patients. In a Phase I study of the drug, dubbed GDC-0941, two of 97 subjects experienced
Genentech sees promise in combining experimental cancer drugs
Genentech has taken two of its most promising cancer programs and run them through a Phase I safety study to see if they should push ahead with more studies. And investigators got the green light
